Core Wealth Advisors (Florida)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-75
Closed -$6.54K – 161
2024
Q1
$6.54K Hold
75
– – ﹤0.01% 212
2023
Q4
$6.18K Hold
75
– – ﹤0.01% 205
2023
Q3
$5.88K Hold
75
– – ﹤0.01% 193
2023
Q2
$6.61K Hold
75
– – ﹤0.01% 184
2023
Q1
$6.05K Hold
75
– – ﹤0.01% 185
2022
Q4
$5.83K Hold
75
– – ﹤0.01% 195
2022
Q3
$6K Hold
75
– – ﹤0.01% 164
2022
Q2
$7K Hold
75
– – ﹤0.01% 161
2022
Q1
$8K Hold
75
– – ﹤0.01% 151
2021
Q4
$8K Hold
75
– – ﹤0.01% 163
2021
Q3
$9K Hold
75
– – 0.01% 140
2021
Q2
$9K Hold
75
– – 0.01% 131
2021
Q1
$9K Hold
75
– – 0.01% 117
2020
Q4
$9K Hold
75
– – 0.01% 116
2020
Q3
$8K Buy
+75
New +$7.53K 0.01% 107
2020
Q1
– Sell
-12
Closed -$1K – 166
2019
Q4
$1K Buy
+12
New +$1.32K ﹤0.01% 126

Other funds holding MDT

Core Wealth Advisors (Florida)'s MDT Position: Q2 2024 in Review

Core Wealth Advisors (Florida) sold out of Medtronic (MDT) in Q2 2024, closing a stake of 75 shares — an estimated $6.54K sold.

Core Wealth Advisors (Florida) first reported a position in MDT in Q4 2019 and held it in 16 quarters. The position peaked at $9K in Q3 2021. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Core Wealth Advisors (Florida) reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 75 Medtronic shares in Q2 2024, an estimated $6.54K.
  • Core Wealth Advisors (Florida) first reported a position in Medtronic in Q4 2019 and held it in 16 quarters.
  • Core Wealth Advisors (Florida)'s Medtronic position peaked at $9K in Q3 2021.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2024, filed 15 Aug 2024.